Insulin resistance and postprandial triglyceride levels in primary renal disease

Metabolism: Clinical and Experimental

Volumn 54, Issue 6, 2005, Pages 821-828

  Charlesworth, John A ^a   Kriketos, Adamandia D ^b   Jones, Jane E ^a   Erlich, Jonathan H ^a   Campbell, Lesley V ^b   Peake, Philip W ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b ST VINCENT S HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

FATTY ACID; GLUCOSE; INSULIN; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; BODY COMPOSITION; BODY FAT; CHOLESTEROL DIET; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DIET RESTRICTION; FATTY ACID BLOOD LEVEL; FEMALE; GLUCOSE BLOOD LEVEL; HORMONE DETERMINATION; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; INSULIN SENSITIVITY; KIDNEY DISEASE; LINEAR REGRESSION ANALYSIS; LIPID BLOOD LEVEL; MALE; METABOLIC ACTIVATION; PANCREAS ISLET BETA CELL; POSTPRANDIAL STATE; PRIORITY JOURNAL; TRIACYLGLYCEROL BLOOD LEVEL;

ADULT; AGED; BODY MASS INDEX; CREATININE; DIETARY FATS; FEMALE; HUMANS; INSULIN RESISTANCE; KIDNEY DISEASES; MALE; METABOLIC CLEARANCE RATE; MIDDLE AGED; POSTPRANDIAL PERIOD; TRIGLYCERIDES;

EID: 19444385531     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.metabol.2005.01.028     Document Type: Article

References (30)

1. J.P. Despres, B. Lamarch, and P. Mauriege Hyperinsulinemia as an independent risk factor for ischemic heart disease N Engl J Med 334 1996 952 957
2. S.M. Haffner Epidemiology of insulin resistance and its relation to coronary artery disease Am J Cardiol 84 1999 11J 14J
3. R.A. DeFronzo, D. Smith, and A. Alvestrand Insulin action in uremia Kidney Int 24 Suppl 16 1983 S102 S124
4. R.N. Foley, P.S. Parfrey, and M.J. Sarnak Clinical epidemiology of cardiovascular disease in chronic renal failure Am J Kidney Dis 32 Suppl 5 1998 S112 S119
5. P.O. Attman, and P. Alaupovic Lipid and apolipoprotein profiles of uremic dyslipoproteinemia-relation to renal function and dialysis Nephron 57 1991 401
6. K.W. Ma, E.L. Greene, and L. Rau Cardiovascular risk factors in chronic renal failure and hemodialysis populations Am J Kidney Dis 19 1992 505 513
7. K. Vareesangthip, P. Tong, and R. Wilkinson Insulin resistance in adult polycystic kidney disease Kidney Int 52 1997 503 508
8. K. Vareesangthip, T.H. Thomas, and P. Tong Abnormal erythrocyte membrane fluidity in adult polycystic kidney disease: difference between intact cells and ghost membranes Eur J Clin Invest 26 1996 171 173
9. P. Tong, T. Thomas, and T. Berrish Cell membrane dynamics and insulin resistance in non-insulin-dependent diabetes mellitus Lancet 345 1995 357 358
10. D. Fliser, G. Pacini, and R. Engelleiter Insulin resistance and hyperinsulinemia are already present in patients with incipient renal disease Kidney Int 53 1998 1343 1347
11. C. Hollenbeck, and G.M. Reaven Variations in insulin-stimulated glucose uptake in healthy individuals with normal glucose tolerance J Clin Endocrinol Metab 64 1987 1169 1173
12. M. Stern, and S. Haffner Body fat distribution and hyperinsulinemia as risk factors for diabetes and cardiovascular disease Arteriosclerosis 6 1986 123 130
13. D.G.P. Carey, A.B. Jenkins, and L.V. Campbell Abdominal fat and insulin resistance in normal and overweight women: direct measurements reveal a strong relationship in subjects at both low and high risk of NIDDM Diabetes 45 1996 633 638
14. D.B. Zilversmit Atherogenesis: a postprandial phenomenon Circulation 60 1979 473 485
15. J.R. Patsch Triglyceride-rich lipoproteins and atherosclerosis Atherosclerosis 110 Suppl 3 1994 523 526
16. D.R. Mathews, J.P. Hosker, and A.S. Rudenski Homeostasis model assessment: insulin resistance and Beta-cell function from fasting plasma glucose and insulin concentrations in man Diabetologia 28 1985 412 419
17. M. Kanauchi, Y. Akai, and T. Hashimoto Validation of simple indices to assess insulin sensitivity and pancreatic Beta-cell function in patients with renal dysfunction Nephron 92 3 2002 713 715
18. A.D. Kriketos, W. Sam, and T. Schubert Postprandial triglycerides in response to high fat: role of dietary carbohydrate Eur J Clin Invest 33 2003 383 389
19. R.A. De Fronzo, A. Alvestrand, and D. Smith Insulin resistance in uremia J Clin Invest 67 1981 563 568
20. P. Lee, D. O'Neal, and B. Murphy The role of abdominal adiposity and insulin resistance in dyslipidemia of chronic renal failure Am J Kidney Dis 29 1997 54 65
21. K. Shinohara, T. Shoji, and M. Emoto Insulin resistance as an independent predictor of cardiovascular mortality in patients with end-stage renal disease J Am Soc Nephrol 13 2002 1894 1900
22. I. Eidemak, B. Feldt-Rasmussen, and I.-L. Kanstrup Insulin resistance and hyperinsulinaemia in mild to moderate progressive chronic renal failure and its association with aerobic work capacity Diabetologia 38 1995 565 572
23. A. Alvestrand, M. Mujagic, and A. Wajngot Glucose intolerance in uremic patients: the relative contribution of impaired β-cell function and insulin resistance Clin Nephrol 31 1989 175 183
24. M. Axelsen, U. Smith, and J. Eriksson Postprandial hypertriglyceridemia and insulin resistance in normoglycemic first-degree relatives of patients with Type 2 diabetes Ann Intern Med 131 1999 27 31
25. M. Weintraub, A. Burstein, and T. Rassin Severe defect in clearing postprandial chylomicron remnants in dialysis patients Kidney Int 42 1992 1247 1252
26. T. Quaschning, V. Kraqne, and T. Metzger Abnormalities in uremic lipoprotein metabolism and its impact on cardiovascular disease Am J Kidney 38 Suppl 1 2001 S14 S19
27. S.I. McFarlane, A. Kumar, and J.R. Sowers Mechanisms by which angiotensin-converting enzyme inhibitors prevent diabetes and cardiovascular disease Am J Cardiol 91 12A 2003 30H 37H
28. H. Tezcan, D. Yavuz, and A. Toprak Effect of angiotensin-converting enzyme inhibition on endothelial function and insulin sensitivity in hypertensive patients J Renin Angiotensin Aldosterone System 4 2003 119 123
29. G. Andronico, R. Ferraro-Mortellaro, and M.T. Mangano Insulin resistance and glomerular hemodynamics in essential hypertension Kidney Int 62 2002 1005 1009
30. S. Klahr, and J.J. Morrissey The role of vasoactive compounds, growth factors and cytokines in the progression of renal disease Kidney Int Suppl 75 2000 S7 S14